Reply to the Letter to the Editor “Is it time to abandon drug-eluting stents for saphenous venous graft percutaneous coronary intervention?” Elgendy I, Mahmoud A, Brilakis E, Bavry A June 20, 2019 | 10.4244/EIJ-D-18-00666R
Other coronary interventions Drug-eluting stents versus bare metal stents for saphenous vein graft revascularisation: a meta-analysis of randomised trials Elgendy I, Mahmoud A, Brilakis E, Bavry A June 20, 2018 | 10.4244/EIJ-D-17-00839
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
JAA This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more December 3, 2019
Trials Book New update! Discover 17 new trials (The Trials book is supported by Biotronik) October 29, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019